IRIS
PELAIA, GIROLAMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.445
AS - Asia 3.995
EU - Europa 1.585
SA - Sud America 1.134
AF - Africa 79
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 12.255
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.247
SG - Singapore 1.822
CN - Cina 895
BR - Brasile 876
IT - Italia 765
VN - Vietnam 497
IN - India 354
DE - Germania 189
GB - Regno Unito 167
HK - Hong Kong 150
SE - Svezia 143
CA - Canada 125
AR - Argentina 109
FI - Finlandia 72
EC - Ecuador 46
BD - Bangladesh 45
ID - Indonesia 45
MX - Messico 42
NL - Olanda 33
ES - Italia 29
IQ - Iraq 29
FR - Francia 28
RU - Federazione Russa 28
PY - Paraguay 23
VE - Venezuela 22
PL - Polonia 21
TR - Turchia 21
UA - Ucraina 21
JP - Giappone 19
ZA - Sudafrica 19
CL - Cile 17
PE - Perù 16
PK - Pakistan 16
CO - Colombia 14
MA - Marocco 14
CZ - Repubblica Ceca 13
DO - Repubblica Dominicana 13
EG - Egitto 13
IE - Irlanda 12
TW - Taiwan 12
UZ - Uzbekistan 11
SA - Arabia Saudita 10
AT - Austria 9
IL - Israele 9
UY - Uruguay 9
AU - Australia 8
LT - Lituania 8
RO - Romania 8
DZ - Algeria 7
KE - Kenya 7
LB - Libano 7
JO - Giordania 6
MY - Malesia 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
EU - Europa 5
IR - Iran 5
CH - Svizzera 4
CR - Costa Rica 4
DK - Danimarca 4
KZ - Kazakistan 4
NP - Nepal 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
AZ - Azerbaigian 3
BN - Brunei Darussalam 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
OM - Oman 3
PH - Filippine 3
PR - Porto Rico 3
AL - Albania 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
KR - Corea 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
GY - Guiana 1
JM - Giamaica 1
KW - Kuwait 1
ML - Mali 1
Totale 12.247
Salva come PNG Salva come JPEG
Città #
San Jose 1.022
Singapore 593
Chandler 574
Ashburn 489
Dallas 367
Santa Clara 319
Bengaluru 288
Hefei 288
Milan 248
Lawrence 227
Princeton 227
Ho Chi Minh City 199
Hong Kong 146
Wilmington 144
Beijing 132
Chicago 117
Munich 117
London 116
Hanoi 98
Ottawa 91
São Paulo 82
Catanzaro 73
Des Moines 71
Turku 51
Boardman 49
New York 34
Los Angeles 33
Naples 31
Shanghai 30
Da Nang 26
Rio de Janeiro 26
Rome 26
Quito 22
San Francisco 22
Haiphong 21
Palermo 21
Warsaw 21
Atlanta 19
Guangzhou 19
Redwood City 19
Brooklyn 18
Helsinki 18
Mexico City 18
Norwalk 18
The Dalles 18
Hanover 17
Seattle 17
Biên Hòa 16
Buenos Aires 16
Florence 16
San Nicola Manfredi 16
Belo Horizonte 15
Boston 15
Council Bluffs 15
Redmond 15
Troina 15
Baghdad 14
Orem 14
Curitiba 13
Lima 13
Olomouc 13
Phoenix 13
Salvador 13
Thái Bình 13
Tokyo 13
Columbus 12
Dhaka 12
Guayaquil 12
Ankara 11
Hải Dương 11
Ninh Bình 11
Shenzhen 11
Tashkent 11
Dublin 10
Paris 10
Amsterdam 9
Asunción 9
Campinas 9
Chennai 9
Pune 9
Brasília 8
Cairo 8
Guarulhos 8
Johannesburg 8
New Delhi 8
Osasco 8
Porto Alegre 8
Santo Domingo 8
Taipei 8
Toronto 8
Augusta 7
Bauru 7
Cape Town 7
Falls Church 7
Frankfurt am Main 7
Goiânia 7
Manchester 7
Mendoza 7
Montevideo 7
Pelotas 7
Totale 7.186
Salva come PNG Salva come JPEG
Nome #
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-independent and associated with an increase of CD25(+) cells 127
Arg16Gly 132-Adrenoreceptor Polymorphism in Severe Eosinophilic Asthma: Implications for Mepolizumab Long-Term Effectiveness and Clinical Remission 96
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 96
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 89
Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-α and Haemophilus influenzae in human bronchial epithelial cells 88
Ruolo dei calcio-antagonisti nella prevenzione e nel trattamento dell’asma bronchiale 87
High-flow nasal oxygen therapy in intensive care and anaesthesia 82
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 81
Application of proteomics and peptidomics to COPD 79
High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial 78
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 75
A case of Hughes-Stovin sindrome associated with Budd-Chiari sindrome 74
Adverse drug reactions to antibiotics observed in two pulmonology divisions of Catanzaro, Italy: A six-year retrospective study 73
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 73
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 72
Type 2 severe asthma: pathophysiology and treatment with biologics 70
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 70
Asthma and COPD proteomics: Current approaches and future directions 69
Peptidomic analysis of induced sputum of asthmatic patients by MSB-MALDI-TOF-MS platform 68
Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts 68
Alpha-interferon and its effects on signal transduction pathways 67
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 67
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study 66
A single-blind comparative study of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 66
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 66
Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ET(A) receptor-dependent activation of MAP kinases 66
A case of Hughes-Stovin syndrome associated with Budd-Chiari syndrome 66
The sodium-phosphate co-transporter SLC34A2, and pulmonary alveolar microlithiasis: presentation of an inbred family and a novel truncating mutation in exon 3 65
Is the mitochondrial benzodiazepine receptor involved in the control of airway smooth muscle tone? 64
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy 64
Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach 64
A case of alveolar proteinosis associated with pulmonary nocardiosis 63
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases 63
Asthma management in a specialist setting: results of an Italian Respiratory Society survey 63
Objective and self-evaluation voice analysis after transoral laser cordectomy and radiotherapy in T1a-T1b glottic cancer 63
A single-blind, partial crossover clinical trial of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 61
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 61
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD 60
Effects of Ambrisentan in a Patient Affected by Combined Pulmonary Fibrosis and Emphysema and by Severe Pulmonary Hypertension: Clinical, Functional, and Biomolecular Findings 60
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non small lung cancer cells. 60
Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations 60
LEBRIKIZUMAB Anti-interleukin-13 monoclonal antibody, Treatment of asthma 60
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 60
Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments 59
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 58
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 58
Benralizumab:from the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 57
Airways smooth muscle response to biological stimuli 57
Application of MSB-MALDI-TOF-MS Technology to body fluids and Tissues peptidome profiling 57
A rare case of infection of the lower respiratory tract caused by Bordetella bronchiseptica 57
Molecular mechanisms underlying airway smooth muscle contraction and proliferation: Implications for asthma 57
Adverse drug reactions in hospitalized patients following antibiotics administration 56
Anticolinergici 56
Valutazione in doppio cieco dell’effetto broncodilatante del procaterolo somministrato per aerosol dosato 56
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 54
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 54
Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury 54
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 53
Emerging biological treatments for asthma 53
Kartagener's syndrome in a woman with a normal ciliary structure and an intracranial meningioma 53
Role of biologics in severe eosinophilic asthma - focus on reslizumab 53
Early management of COPD: where are we now and where do we go from here? 53
Effects of MAPK inhibitors on H2O2-induced IL-8 production and cell death in primary cultures of human bronchial epithelial cells 53
Use of narrative medicine to identify key factors for effective doctor-patient relationships in severe asthma 53
Oxygenation strategies during flexible bronchoscopy: a review of the literature 53
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial 53
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 53
Agonisti beta2-adrenergici 52
Adverse drug reactions in hospitalized patients following bronchodilators administration 52
Adverse drug reactions in hospitalized patients following NSAIDs administration 52
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide 52
Adverse drug reaction in two pneumology units of Catanzaro 51
Inhibitory effects of the IL-6 receptor superantagonist SANT7 on MAP kinase phosphorylation and cell proliferation induced by IL-6 and TGF-beta1in human lung fibroblasts 51
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma 51
Basi fisiopatologiche della terapia del broncospasmo 50
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 50
Effects of transforming growth factor-β and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells 50
Phenotyping severe asthma: a rationale for biologic therapy 50
Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence. 50
Real-Life Effects of Omalizumab on Chronic Rhinosinusitis with Nasal Polyposis 49
Effects of glucocorticoids on activation of c-jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells 49
Nitric oxide in upper airways inflammatory diseases 49
Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry. 49
STRUCTURE OF THE RAT GENE ENCODING THE MITOCHONDRIAL BENZODIAZEPINE RECEPTOR 49
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-indipendent and associated with an increase of CD25+ cells 49
Effects of simvastatin and rosuvastatin on RAS protein, matrix metalloproteinases and NF-kappa B in lung cancer and in normal pulmonary tissues 49
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy 49
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma 49
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 49
Predictors of renal function worsening in patients with chronic obstructive pulmonary disease (Copd): A multicenter observational study 49
The severe asthma network in Italy: findings and perspectives 48
Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases 48
Effects of non-bronchoconstrictive doses of inhaled propranolol on airway responsiveness to methacholine 48
P38 signalling pathway in primary cultures of human bronchial epithelial cells: effects of transforming growth factor-β and pharmacological modulation by budesonide 48
T CELL ACTIVATION STATE IN THE INDUCED SPUTUM OF ASTHMATICS TREATED WITH BUDESONIDE 48
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for biomarker discovery of Asthma and COPD 48
Real-world experience with benralizumab in patients with severe eosinophilic asthma: A case series 48
Effects of transforming growth factor-beta and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells 47
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 47
Retrospective analysis of adverse drug reactions induced by gemcitabine treatment in patients with non-small cell lung cancer 47
Totale 6.017
Salva come PNG Salva come JPEG
Categoria #
all - tutte 118.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.614
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 25 6 7
2021/2022584 4 5 19 111 46 18 31 141 53 57 89 10
2022/20231.692 465 65 66 127 182 169 16 116 276 78 110 22
2023/2024686 143 90 59 37 36 169 14 24 8 27 24 55
2024/20252.718 412 137 97 105 194 344 93 75 348 144 280 489
2025/20266.372 325 754 762 1.269 643 274 806 369 857 313 0 0
Totale 12.511